$105.36
Price
$10.5B
Market Cap
18.0
P/E Ratio
16.1
Forward P/E
$5.84
EPS (TTM)
0.72%
Dividend Yield
$110M
Cash
$2.7B
Total Debt
99M
Shares Out
$92.77
$127.99
52-Week Range
Institutional Ownership of ENCOMPASS HEALTH CORP
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ENCOMPASS HEALTH CORP
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| SELL | -12.0% | 50.7K | $6M | $120.22 | |
| 2025-Q2 | |||||
| SELL | -18.7% | 57.6K | $7M | $118.61 | |
| 2025-Q1 | |||||
| SELL | -13.3% | 70.8K | $7M | $98.60 | |
| 2024-Q4 | |||||
| SELL | -11.4% | 81.7K | $8M | $98.66 | |
| 2024-Q3 | |||||
| SELL | -2.3% | 92.2K | $9M | $90.64 | |
| 2024-Q2 | |||||
| SELL | -6.1% | 94.4K | $8M | $84.50 | |
| 2024-Q1 | |||||
| SELL | -4.7% | 100.5K | $8M | $73.55 | |
| 2023-Q3 | |||||
| SELL | -14.0% | 105.5K | $7M | $69.09 | |
| 2023-Q2 | |||||
| SELL | -3.1% | 122.7K | $8M | $62.30 | |
| 2022-Q4 | |||||
| SELL | EXIT | — | — | $56.00 | |
| SELL | -4.8% | 126.7K | $8M | $56.00 | |
| 2022-Q2 | |||||
| SELL | -1.7% | 3.0M | $165M | $51.59 | |
| BUY | +5.2% | 133.0K | $7M | $51.59 | |
| 2022-Q1 | |||||
| BUY | +318.9% | 3.0M | $213M | $52.43 | |
| BUY | +27.4% | 126.5K | $9M | $52.43 | |
| 2021-Q4 | |||||
| BUY | NEW | 716.1K | $47M | $50.83 | |
| BUY | +10.1% | 99.2K | $6M | $50.83 | |
| 2021-Q3 | |||||
| BUY | +44.1% | 90.2K | $7M | $63.23 | |
| 2021-Q2 | |||||
| BUY | +8.7% | 62.6K | $5M | $67.27 | |
| 2021-Q1 | |||||
| SELL | EXIT | — | — | $65.25 | |
| BUY | +40.4% | 57.5K | $5M | $65.25 | |
| 2020-Q4 | |||||
| SELL | -20.3% | 2.6M | $219M | $57.31 | |
| BUY | +12.2% | 41.0K | $3M | $57.31 | |
| 2020-Q3 | |||||
| BUY | +23.8% | 3.3M | $215M | $51.63 | |
| BUY | +34.9% | 36.5K | $2M | $51.63 | |
| 2020-Q2 | |||||
| BUY | +85.2% | 2.7M | $166M | $53.98 | |
| BUY | +19.2% | 27.1K | $2M | $53.98 | |
| 2020-Q1 | |||||
| BUY | NEW | 1.4M | $93M | $61.38 | |
| SELL | -10.3% | 22.7K | $1M | $61.38 | |
| 2019-Q4 | |||||
| BUY | +2.5% | 25.3K | $2M | $55.31 | |
| 2019-Q3 | |||||
| BUY | +12.8% | 24.7K | $2M | $50.29 | |
| 2019-Q2 | |||||
| BUY | +7.9% | 21.9K | $1M | $48.33 | |
| 2019-Q1 | |||||
| BUY | +18.6% | 20.3K | $1M | $51.72 | |
| 2018-Q4 | |||||
| BUY | +16.3% | 17.1K | $1M | $57.56 | |
| 2018-Q3 | |||||
| SELL | -8.0% | 14.7K | $1M | $62.23 | |
| 2018-Q1 | |||||
| BUY | +4.6% | 16.0K | $915000 | $42.18 | |
Insider Trading for ENCOMPASS HEALTH CORP
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.